BioGaia AB (publ) (BIOG-B.ST)
Makes probiotic products for digestive, oral, and immune health.
114.10-0.01%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+19.5%
The outlook
BioGaia trades at 114.1 with limited but unanimous analyst coverage showing a Strong Buy rating, and the average price target sits roughly 34% above current levels. The stock is positioned in the lower-to-middle portion of its 52-week range with mixed momentum versus its moving averages. The elevated trailing P/E of 33.3 reflects market pricing relative to current earnings.
What’s behind the score
Analyst consensusStrong Buy — 1.0 avg of 2 analysts
Price trendMixed vs its moving averages
52-week range48% of the way from its 52-week low to high
Price targetAvg target +34% vs current price
Analyst price target
~12-month · 2 analysts152.50average target+33.7% vs now
Now 114.10
Low 140.00High 165.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$11.54B
52-wk high
136.30
52-wk low
93.20
50-day avg
121.59
200-day avg
112.53
Trailing P/E
33.3